Histone deacetylases and cardiometabolic diseases

Kan Hui Yiew, Tapan Kumar Chatterjee, David Y. Hui, Neal Lee Weintraub

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Cardiometabolic disease, emerging as a worldwide epidemic, is a combination of metabolic derangements leading to type 2 diabetes mellitus and cardiovascular disease. Genetic and environmental factors are linked through epigenetic mechanisms to the pathogenesis of cardiometabolic disease. Post-translational modifications of histone tails, including acetylation and deacetylation, epigenetically alter chromatin structure and dictate cell-specific gene expression patterns. The histone deacetylase family comprises 18 members that regulate gene expression by altering the acetylation status of nucleosomal histones and by functioning as nuclear transcriptional corepressors. Histone deacetylases regulate key aspects of metabolism, inflammation, and vascular function pertinent to cardiometabolic disease in a cell- and tissue-specific manner. Histone deacetylases also likely play a role in the metabolic memory of diabetes mellitus, an important clinical aspect of the disease. Understanding the molecular, cellular, and physiological functions of histone deacetylases in cardiometabolic disease is expected to provide insight into disease pathogenesis, risk factor control, and therapeutic development.

Original languageEnglish (US)
Pages (from-to)1914-1919
Number of pages6
JournalArteriosclerosis, thrombosis, and vascular biology
Volume35
Issue number9
DOIs
StatePublished - Sep 28 2015

Fingerprint

Histone Deacetylases
Acetylation
Histones
Gene Expression
Co-Repressor Proteins
Post Translational Protein Processing
Epigenomics
Type 2 Diabetes Mellitus
Chromatin
Blood Vessels
Diabetes Mellitus
Cardiovascular Diseases
Inflammation

Keywords

  • cardiovascular
  • histone deacetylases
  • inflammation
  • metabolic disease
  • sirtuins

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Histone deacetylases and cardiometabolic diseases. / Yiew, Kan Hui; Chatterjee, Tapan Kumar; Hui, David Y.; Weintraub, Neal Lee.

In: Arteriosclerosis, thrombosis, and vascular biology, Vol. 35, No. 9, 28.09.2015, p. 1914-1919.

Research output: Contribution to journalArticle

Yiew, Kan Hui ; Chatterjee, Tapan Kumar ; Hui, David Y. ; Weintraub, Neal Lee. / Histone deacetylases and cardiometabolic diseases. In: Arteriosclerosis, thrombosis, and vascular biology. 2015 ; Vol. 35, No. 9. pp. 1914-1919.
@article{a10be0f4ef014023a6433229518ca9e3,
title = "Histone deacetylases and cardiometabolic diseases",
abstract = "Cardiometabolic disease, emerging as a worldwide epidemic, is a combination of metabolic derangements leading to type 2 diabetes mellitus and cardiovascular disease. Genetic and environmental factors are linked through epigenetic mechanisms to the pathogenesis of cardiometabolic disease. Post-translational modifications of histone tails, including acetylation and deacetylation, epigenetically alter chromatin structure and dictate cell-specific gene expression patterns. The histone deacetylase family comprises 18 members that regulate gene expression by altering the acetylation status of nucleosomal histones and by functioning as nuclear transcriptional corepressors. Histone deacetylases regulate key aspects of metabolism, inflammation, and vascular function pertinent to cardiometabolic disease in a cell- and tissue-specific manner. Histone deacetylases also likely play a role in the metabolic memory of diabetes mellitus, an important clinical aspect of the disease. Understanding the molecular, cellular, and physiological functions of histone deacetylases in cardiometabolic disease is expected to provide insight into disease pathogenesis, risk factor control, and therapeutic development.",
keywords = "cardiovascular, histone deacetylases, inflammation, metabolic disease, sirtuins",
author = "Yiew, {Kan Hui} and Chatterjee, {Tapan Kumar} and Hui, {David Y.} and Weintraub, {Neal Lee}",
year = "2015",
month = "9",
day = "28",
doi = "10.1161/ATVBAHA.115.305046",
language = "English (US)",
volume = "35",
pages = "1914--1919",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Histone deacetylases and cardiometabolic diseases

AU - Yiew, Kan Hui

AU - Chatterjee, Tapan Kumar

AU - Hui, David Y.

AU - Weintraub, Neal Lee

PY - 2015/9/28

Y1 - 2015/9/28

N2 - Cardiometabolic disease, emerging as a worldwide epidemic, is a combination of metabolic derangements leading to type 2 diabetes mellitus and cardiovascular disease. Genetic and environmental factors are linked through epigenetic mechanisms to the pathogenesis of cardiometabolic disease. Post-translational modifications of histone tails, including acetylation and deacetylation, epigenetically alter chromatin structure and dictate cell-specific gene expression patterns. The histone deacetylase family comprises 18 members that regulate gene expression by altering the acetylation status of nucleosomal histones and by functioning as nuclear transcriptional corepressors. Histone deacetylases regulate key aspects of metabolism, inflammation, and vascular function pertinent to cardiometabolic disease in a cell- and tissue-specific manner. Histone deacetylases also likely play a role in the metabolic memory of diabetes mellitus, an important clinical aspect of the disease. Understanding the molecular, cellular, and physiological functions of histone deacetylases in cardiometabolic disease is expected to provide insight into disease pathogenesis, risk factor control, and therapeutic development.

AB - Cardiometabolic disease, emerging as a worldwide epidemic, is a combination of metabolic derangements leading to type 2 diabetes mellitus and cardiovascular disease. Genetic and environmental factors are linked through epigenetic mechanisms to the pathogenesis of cardiometabolic disease. Post-translational modifications of histone tails, including acetylation and deacetylation, epigenetically alter chromatin structure and dictate cell-specific gene expression patterns. The histone deacetylase family comprises 18 members that regulate gene expression by altering the acetylation status of nucleosomal histones and by functioning as nuclear transcriptional corepressors. Histone deacetylases regulate key aspects of metabolism, inflammation, and vascular function pertinent to cardiometabolic disease in a cell- and tissue-specific manner. Histone deacetylases also likely play a role in the metabolic memory of diabetes mellitus, an important clinical aspect of the disease. Understanding the molecular, cellular, and physiological functions of histone deacetylases in cardiometabolic disease is expected to provide insight into disease pathogenesis, risk factor control, and therapeutic development.

KW - cardiovascular

KW - histone deacetylases

KW - inflammation

KW - metabolic disease

KW - sirtuins

UR - http://www.scopus.com/inward/record.url?scp=84940385931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940385931&partnerID=8YFLogxK

U2 - 10.1161/ATVBAHA.115.305046

DO - 10.1161/ATVBAHA.115.305046

M3 - Article

C2 - 26183616

AN - SCOPUS:84940385931

VL - 35

SP - 1914

EP - 1919

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 9

ER -